Data / Form D filings / CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc.: Form D filings
CytomX Therapeutics, Inc., a biotechnology company in South San Francisco, CA, filed 9 Form D notices with the SEC between 2010 and 2023. The latest, on August 17, 2023, reports $30 million sold of a $30 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 151 OYSTER POINT BLVD., SUITE 400, South San Francisco, CA, 94080
- Phone
- (650) 515-3185
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1501989
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 17, 2023 | New notice | $30,000,000 | $30,000,000 | 4 | Jun 29, 2023 | sec.gov | |
| Jun 25, 2015 | New notice | $69,999,999 | $69,999,999 | 33 | Jun 12, 2015 | sec.gov | |
| Jan 6, 2015 | New notice | $29,999,999 | $16,499,999 | $13,500,000 | 4 | Dec 22, 2014 | sec.gov |
| Aug 10, 2012 | New notice | $25,999,999 | $12,599,999 | $13,400,000 | 3 | Jul 26, 2012 | sec.gov |
| Sep 28, 2010 | New notice | $2,660,000 | $2,660,000 | 1 | Sep 22, 2010 | sec.gov | |
| Sep 28, 2010 | New notice | $30,000,000 | $10,000,000 | $20,000,000 | 2 | Sep 22, 2010 | sec.gov |
| Sep 28, 2010 | New notice | $652,903 | $652,903 | 1 | Sep 22, 2010 | sec.gov | |
| Sep 28, 2010 | New notice | $102,097 | $102,097 | 1 | Sep 22, 2010 | sec.gov | |
| Sep 28, 2010 | New notice | $524,994 | $524,994 | 19 | Sep 22, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Chris Ogden | Executive Officer | |
| Marcia Belvin | Executive Officer | |
| James Meyers | Director | |
| Alan Ashworth | Director | |
| Matthew Young | Director | |
| Jeff Landau | Executive Officer | |
| Halley Gilbert | Director | |
| Wayne Chu | Executive Officer | |
| Elaine Jones | Director | |
| Mani Mohindru | Director | |
| Sean McCarthy | Executive Officer, Director | |
| Lloyd Rowland | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Aug 14, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CytomX Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.